# A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions

> **NCT00495898** · PHASE4 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 200 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** CYPHER sirolimus-eluting stent
- **DEVICE:** uncoated Bx VELOCITY balloon-expandable stent

## Key facts

- **NCT ID:** NCT00495898
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2005-05
- **Final completion:** 2009-11
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2009-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00495898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00495898, "A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00495898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*